AKT2 and central nervous system cancer: Compound 4j inhibited AKT2/PKBβ specifically among 139 purified kinases tested and induced cell death in primary patient-derived glioma 2D cells and 3D neurospheres while being relatively nontoxic towards non-cancerous cells.